SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K Wang, W Guo, N Li, J Shi, C Zhang, W Y Lau, M Wu, S Cheng, Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study, British Journal of Cancer, 2014, 110, 7, 1811

    CrossRef

  2. 2
    Pengfei Zhang, Bizhi Shi, Huiping Gao, Hua Jiang, Juan Kong, Jin Yan, Xiaorong Pan, Kesang Li, Pengwei Zhang, Ming Yao, Shengli Yang, Jianren Gu, Hongyang Wang, Zonghai Li, An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression, Cancer Immunology, Immunotherapy, 2014, 63, 2, 121

    CrossRef

  3. 3
    Ingeborg Tinhofer, Mohammad Saki, Franlziska Niehr, Ulrich Keilholz, Volker Budach, Cancer stem cell characteristics of circulating tumor cells, International Journal of Radiation Biology, 2014, 90, 8, 622

    CrossRef

  4. 4
    H Okabe, T Ishimoto, K Mima, S Nakagawa, H Hayashi, H Kuroki, K Imai, H Nitta, S Saito, D Hashimoto, A Chikamoto, T Ishiko, M Watanabe, O Nagano, T Beppu, H Saya, H Baba, CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma, British Journal of Cancer, 2014, 110, 4, 958

    CrossRef

  5. 5
    Karen L. Morris, Jonathan D. Tugwood, Leila Khoja, Matthew Lancashire, Robert Sloane, Debbie Burt, Patrick Shenjere, Cong Zhou, Clare Hodgson, Toshihiko Ohtomo, Atsuhiko Katoh, Takahiro Ishiguro, Juan W. Valle, Caroline Dive, Circulating biomarkers in hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2014, 74, 2, 323

    CrossRef

  6. 6
    Evi S. Lianidou, Areti Strati, Athina Markou, Circulating tumor cells as promising novel biomarkers in solid cancers*, Critical Reviews in Clinical Laboratory Sciences, 2014, 51, 3, 160

    CrossRef

  7. 7
    Jian-wen Huang, Bing Liu, Bao-shan Hu, Yong Li, Xu He, Wei Zhao, You-bing Zheng, Li-gong Lu, Clinical value of circulating tumor cells for the prognosis of postoperative transarterial chemoembolization therapy, Medical Oncology, 2014, 31, 9

    CrossRef

  8. You have free access to this content8
    Anthony W H Chan, Joanna H M Tong, Stephen L Chan, Paul B S Lai, Ka-Fai To, Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma, Histopathology, 2014, 64, 7
  9. 9
    Henrike Julich, Arnulf Willms, Veronika Lukacs-Kornek, Miroslaw Kornek, Extracellular Vesicle Profiling and Their Use as Potential Disease Specific Biomarker, Frontiers in Immunology, 2014, 5,

    CrossRef

  10. 10
    Ivonne Nel, Hideo A Baba, Frank Weber, Barbara Sitek, Martin Eisenacher, Helmut E Meyer, Joerg F Schlaak, Andreas-Claudius Hoffmann, IGFBP1in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma, Biomarkers in Medicine, 2014, 8, 5, 687

    CrossRef

  11. 11
    Yi-Xiao Liu, Xi-Dai Long, Zhi-Feng Xi, Yun Ma, Xiao-Ying Huang, Jin-Guang Yao, Chao Wang, Tian-Yu Xing, Qiang Xia, MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis, BioMed Research International, 2014, 2014, 1

    CrossRef

  12. 12
    Anna Dubrovska, Report on the International Workshop ‘Cancer stem cells: The mechanisms of radioresistance and biomarker discovery’, International Journal of Radiation Biology, 2014, 90, 8, 607

    CrossRef

  13. 13
    Ivonne Nel, Paul David, Guido G. H. Gerken, Joerg F. Schlaak, Andreas-Claudius Hoffmann, Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma, Hepatology International, 2014, 8, 3, 321

    CrossRef

  14. 14
    Man Li, Baogang Zhang, Zhiguang Zhang, Xia Liu, Xiangjuan Qi, Jianqiu Zhao, Yong Jiang, Haoyu Zhai, Yinglan Ji, Dan Luo, Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer, BioMed Research International, 2014, 2014, 1

    CrossRef

  15. 15
    Qing-Min Fan, Ying-Ying Jing, Guo-Feng Yu, Xing-Rui Kou, Fei Ye, Lu Gao, Rong Li, Qiu-Dong Zhao, Yang Yang, Zheng-Hua Lu, Li-Xin Wei, Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma, Cancer Letters, 2014, 352, 2, 160

    CrossRef

  16. 16
    Taro Yamashita, Xin Wei Wang, Cancer stem cells in the development of liver cancer, Journal of Clinical Investigation, 2013, 123, 5, 1911

    CrossRef

  17. 17
    Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk, Circulating markers for prognosis of hepatocellular carcinoma, Expert Opinion on Medical Diagnostics, 2013, 7, 4, 319

    CrossRef

  18. 18
    Cindy Kin, Evelyn Kidess, George A Poultsides, Brendan C Visser, Stefanie S Jeffrey, Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis, Expert Review of Molecular Diagnostics, 2013, 13, 6, 581

    CrossRef

  19. 19
    Guang Zhang, Zhongxia Wang, Weihuan Luo, Hongbo Jiao, Junhua Wu, Chunping Jiang, Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma, Gastroenterology Research and Practice, 2013, 2013, 1

    CrossRef

  20. 20
    Caecilia H C Sukowati, Claudio Tiribelli, The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy, Expert Review of Gastroenterology & Hepatology, 2013, 7, 8, 749

    CrossRef

  21. 21
    Ana Barradas, Leon Terstappen, Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis, Cancers, 2013, 5, 4, 1619

    CrossRef

  22. 22
    Roongruedee Chaiteerakij, Benyam D. Addissie, Lewis R. Roberts, Update on Biomarkers of Hepatocellular Carcinoma, Clinical Gastroenterology and Hepatology, 2013,

    CrossRef